lactose has been researched along with levodopa in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Block, MR; Boland, MJ; Hagler, L; Hofeldt, FD; Lazarus, EJ | 1 |
Ahlskog, JE; Bailey, PA; Muenter, MD; Stevens, PM | 1 |
von Scheele, C | 1 |
Baumann, G; Chin, L; Lieberman, A | 1 |
1 trial(s) available for lactose and levodopa
Article | Year |
---|---|
Levodopa in restless legs.
Topics: Adolescent; Adult; Aged; Benserazide; Capsules; Child; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lactose; Levodopa; Male; Middle Aged; Restless Legs Syndrome | 1986 |
6 other study(ies) available for lactose and levodopa
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Isolated galactorrhea with normal serum prolactin levels: clinical implications.
Topics: Adult; Female; Follow-Up Studies; Galactorrhea; Humans; Lactation Disorders; Lactose; Levodopa; Menstruation; Pregnancy; Prolactin; Thyroid Function Tests | 1976 |
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Lactose; Levodopa; Male; Methylcellulose; Middle Aged; Oxazines; Parkinson Disease; Pergolide | 1992 |
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |